JP2001500130A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001500130A5 JP2001500130A5 JP1998513020A JP51302098A JP2001500130A5 JP 2001500130 A5 JP2001500130 A5 JP 2001500130A5 JP 1998513020 A JP1998513020 A JP 1998513020A JP 51302098 A JP51302098 A JP 51302098A JP 2001500130 A5 JP2001500130 A5 JP 2001500130A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19637479.0 | 1996-09-13 | ||
| DE19637479A DE19637479A1 (de) | 1996-09-13 | 1996-09-13 | Verfahren zur Herstellung fester pharmazeutischer Formen |
| DE19734011.3 | 1997-08-06 | ||
| DE19734011A DE19734011A1 (de) | 1997-08-06 | 1997-08-06 | Verfahren zur Herstellung fester pharmazeutischer Formen |
| PCT/EP1997/004984 WO1998010752A2 (de) | 1996-09-13 | 1997-09-11 | Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001500130A JP2001500130A (ja) | 2001-01-09 |
| JP2001500130A5 true JP2001500130A5 (enExample) | 2005-04-07 |
| JP4975894B2 JP4975894B2 (ja) | 2012-07-11 |
Family
ID=26029370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51302098A Expired - Fee Related JP4975894B2 (ja) | 1996-09-13 | 1997-09-11 | 押出による固体薬剤剤形の製造方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6221368B1 (enExample) |
| EP (1) | EP0930875B1 (enExample) |
| JP (1) | JP4975894B2 (enExample) |
| KR (1) | KR20000036066A (enExample) |
| CN (1) | CN1230109A (enExample) |
| AT (1) | ATE239452T1 (enExample) |
| AU (1) | AU720535B2 (enExample) |
| BR (1) | BR9711777A (enExample) |
| CA (1) | CA2265532C (enExample) |
| CZ (1) | CZ82999A3 (enExample) |
| DE (1) | DE59710059D1 (enExample) |
| DK (1) | DK0930875T3 (enExample) |
| ES (1) | ES2199373T3 (enExample) |
| HR (1) | HRP970485A2 (enExample) |
| IL (1) | IL128672A0 (enExample) |
| SK (1) | SK26099A3 (enExample) |
| TR (1) | TR199900563T2 (enExample) |
| TW (1) | TW474824B (enExample) |
| WO (1) | WO1998010752A2 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2241342C (en) | 1998-06-15 | 2000-02-08 | Bernard Charles Sherman | Pharmaceutical tablets comprising an nsaid and a prostaglandin |
| DE19857897A1 (de) * | 1998-12-15 | 2000-06-21 | Basf Ag | Verfahren zur Herstellung wäßriger Polymerdispersionen |
| US6733789B1 (en) | 1999-01-21 | 2004-05-11 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| EP1175205B1 (en) * | 1999-11-12 | 2006-06-14 | Abbott Laboratories | Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
| US20040185099A1 (en) * | 2000-01-20 | 2004-09-23 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
| AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
| DE10026698A1 (de) * | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| GB0106469D0 (en) * | 2001-03-15 | 2001-05-02 | Syngenta Ltd | Solid formulation |
| FR2823974B1 (fr) * | 2001-04-25 | 2004-10-15 | Pf Medicament | Pastille medicamenteuse a liberation lente du principe actif |
| GB0113841D0 (en) * | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
| PT1404300E (pt) * | 2001-06-22 | 2009-11-09 | Bend Res Inc | Composições farmacêuticas de dispersões de fármacos e polímeros neutros |
| US20030118652A1 (en) * | 2001-11-15 | 2003-06-26 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
| US20030091633A1 (en) * | 2001-11-15 | 2003-05-15 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
| EP1603548A4 (en) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| WO2004100883A2 (en) * | 2003-05-06 | 2004-11-25 | Bpsi Holdings, Inc. | Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutual dosage forms and methods of preparing the same |
| US20050042284A1 (en) * | 2003-07-11 | 2005-02-24 | Myriad Genetics, Incorporated | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| MXPA06005913A (es) * | 2003-12-04 | 2006-06-27 | Pfizer Prod Inc | Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos. |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| WO2005053639A2 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Controlled release multiparticulates formed with dissolution enhancers |
| KR20080064209A (ko) * | 2003-12-04 | 2008-07-08 | 화이자 프로덕츠 인코포레이티드 | 바람직하게는 폴록사머와 글리세라이드를 함유하는다미립자 아지트로마이신 조성물의 제조를 위해 압출기를사용하는 분무응결 방법 |
| ES2308274T3 (es) * | 2003-12-04 | 2008-12-01 | Pfizer Products Inc. | Procedimiento para fabricar multiparticulados farmaceuticos. |
| EP1689368B1 (en) * | 2003-12-04 | 2016-09-28 | Bend Research, Inc | Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions |
| CA2547597A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate compositions with improved stability |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| WO2006001877A2 (en) * | 2004-04-13 | 2006-01-05 | Myriad Genetics, Inc. | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen |
| EP1745180A1 (en) * | 2004-04-29 | 2007-01-24 | Keystone Retaining Wall Systems, Inc. | Veneers for walls, retaining walls and the like |
| WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| CA2618985A1 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| US7799744B2 (en) * | 2005-03-09 | 2010-09-21 | Halliburton Energy Services, Inc. | Polymer coated particulates |
| US20090220596A1 (en) * | 2005-07-05 | 2009-09-03 | Abbott Gmbh & Co. Kg | Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix |
| US20070042034A1 (en) * | 2005-07-22 | 2007-02-22 | Myriad Genetics, Incorporated | High drug load formulations and dosage forms |
| EP1832281A1 (en) * | 2006-03-10 | 2007-09-12 | Abbott GmbH & Co. KG | Process for producing a solid dispersion of an active ingredient |
| US20080033045A1 (en) * | 2006-07-07 | 2008-02-07 | Myriad Genetics, Incorporated | Treatment of psychiatric disorders |
| AU2007287793A1 (en) * | 2006-08-23 | 2008-02-28 | Bayer Cropscience Ag | Formulations for the controlled release of agrochemical active agents |
| US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
| EP2293779A1 (en) * | 2008-04-24 | 2011-03-16 | Evestra, Inc. | Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen |
| AU2015317358A1 (en) | 2014-09-19 | 2017-04-27 | Board Of Regents, The University Of Texas System | Methods of preparing extrudates |
| CN108421497A (zh) * | 2018-04-03 | 2018-08-21 | 杨高品 | 药物连续化制粒的生产工艺和设备 |
| KR20250119038A (ko) | 2024-01-31 | 2025-08-07 | 주식회사 이엔케이글로벌 | 신축성재질 성형틀 기반의 고흡수성 고형 제형 흡습제 제조 장비 |
| KR102757752B1 (ko) | 2024-01-31 | 2025-01-21 | (주) 제이아리 | 강성재질 성형틀 기반의 고형 제형 흡습제 제조 장비 |
| KR102857226B1 (ko) | 2024-02-01 | 2025-09-09 | (주) 제이아리 | 고흡수성 고형 제형 흡습제 제조 장비 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1388786A (en) * | 1972-04-03 | 1975-03-26 | Scherer Corp R P | Integral solid gel-lattice dosage form of high-moisture content |
| EP0080862B1 (en) * | 1981-12-02 | 1985-09-25 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
| DE3208791A1 (de) | 1982-03-11 | 1983-09-22 | Röhm GmbH, 6100 Darmstadt | Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels |
| DE3421860C2 (de) * | 1984-06-13 | 1994-09-15 | Roehm Gmbh | Verfahren zum Überziehen von Arzneiformen |
| IL81419A0 (en) * | 1986-01-30 | 1987-08-31 | Syntex Inc | Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation |
| DE3612212A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
| DE3612211A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
| JPS63222112A (ja) | 1987-03-10 | 1988-09-16 | Nippon Soda Co Ltd | 徐放性顆粒 |
| JPS63222121A (ja) * | 1987-03-10 | 1988-09-16 | Nippon Soda Co Ltd | 徐放性ゲル製剤 |
| DE3812567A1 (de) | 1988-04-15 | 1989-10-26 | Basf Ag | Verfahren zur herstellung pharmazeutischer mischungen |
| DE3830353A1 (de) | 1988-09-07 | 1990-03-15 | Basf Ag | Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen |
| DE4031881C2 (de) | 1990-10-08 | 1994-02-24 | Sanol Arznei Schwarz Gmbh | Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung |
| GB9025372D0 (en) | 1990-11-22 | 1991-01-09 | Nat Res Dev | Pharmaceutical dosage forms |
| NL9100691A (nl) * | 1991-04-19 | 1992-11-16 | Dmv Campina Bv | Tabletteerhulpstof. |
| DE4138513A1 (de) * | 1991-11-23 | 1993-05-27 | Basf Ag | Feste pharmazeutische retardform |
| DE4141268A1 (de) | 1991-12-14 | 1993-06-17 | Merck Patent Gmbh | Pharmazeutische zubereitung |
| US5260074A (en) * | 1992-06-22 | 1993-11-09 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| JPH06218028A (ja) | 1992-10-02 | 1994-08-09 | Eisai Co Ltd | 湿製錠の成型方法とその装置及び湿製錠 |
| EP0729748B1 (en) * | 1993-11-18 | 2003-02-26 | Nippon Shinyaku Company, Limited | Process for producing stable medicinal composition |
| DK0739198T3 (da) * | 1994-01-20 | 2004-01-26 | Agres Ltd | Anordning til indgivelse af gavnlige materialer til drøvtyggere |
| US6787156B1 (en) * | 1994-02-23 | 2004-09-07 | Bm Research A/S | Controlled release composition |
-
1997
- 1997-09-10 TW TW086113103A patent/TW474824B/zh active
- 1997-09-10 HR HR19734011.3A patent/HRP970485A2/xx not_active Application Discontinuation
- 1997-09-11 AT AT97942022T patent/ATE239452T1/de active
- 1997-09-11 EP EP97942022A patent/EP0930875B1/de not_active Expired - Lifetime
- 1997-09-11 WO PCT/EP1997/004984 patent/WO1998010752A2/de not_active Ceased
- 1997-09-11 ES ES97942022T patent/ES2199373T3/es not_active Expired - Lifetime
- 1997-09-11 DE DE59710059T patent/DE59710059D1/de not_active Expired - Lifetime
- 1997-09-11 IL IL12867297A patent/IL128672A0/xx unknown
- 1997-09-11 KR KR1019997002072A patent/KR20000036066A/ko not_active Withdrawn
- 1997-09-11 AU AU43846/97A patent/AU720535B2/en not_active Ceased
- 1997-09-11 TR TR1999/00563T patent/TR199900563T2/xx unknown
- 1997-09-11 CZ CZ99829A patent/CZ82999A3/cs unknown
- 1997-09-11 BR BR9711777A patent/BR9711777A/pt not_active Application Discontinuation
- 1997-09-11 DK DK97942022T patent/DK0930875T3/da active
- 1997-09-11 CA CA002265532A patent/CA2265532C/en not_active Expired - Lifetime
- 1997-09-11 SK SK260-99A patent/SK26099A3/sk unknown
- 1997-09-11 CN CN97197941A patent/CN1230109A/zh active Pending
- 1997-09-11 US US09/254,558 patent/US6221368B1/en not_active Expired - Lifetime
- 1997-09-11 JP JP51302098A patent/JP4975894B2/ja not_active Expired - Fee Related